Health Condition 1: H048- Other disorders of lacrimal system
Conditions
Interventions
Intervention1: Carboxymethyl Cellulose: 0.5 percentage QID for 1 year in a single drop dispensing device
Control Intervention1: Carboxymethyl Cellulose: 0.5 percentage QID for 1 year in commercially a
Sponsors
Dr Smriti Sarathi
Eligibility
Inclusion criteria
Inclusion criteria: 1.Participants must have a confirmed diagnosis of dry eye syndrome based on clinical evaluations, such as the Schirmer s test and patient-reported symptoms. 2.Participants aged 16 years and older who can use the eye drops independently. 3. Participants must provide written informed consent to participate in the study. 4.Participants should be able to follow the study protocol, including completing questionnaires and attending follow-up visits.
Exclusion criteria
Exclusion criteria: 1.Individuals who have undergone ocular surgery (e.g., cataract surgery, LASIK) within the last 6 months. 2.Participants currently using other prescription eye drops or medications that may interfere with the study outcomes. 3.Presence of other severe ocular conditions (e.g., severe allergic conjunctivitis, corneal ulcers) that could confound the results. 4.Individuals with systemic diseases affecting tear production (e.g., Rheumatoid Arthritis) that are not stable or well-controlled. 5.Known allergies to carboxy methyl cellulose or other components in the formulation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| dry eye reliefTimepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Smriti Sarathi
Saveetha Medical College and Hospital
Outcome results
None listed